Clinical Trials Directory

Trials / Completed

CompletedNCT05410379

Antral Lesions Characterization of a New Cryoballoon Ablation System in Terms of Local Impedance Drop

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Maria Cecilia Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Atrial fibrillation (AF) is defined as a supraventricular tachyarrhythmia with uncoordinated atrial electrical activation and consequently ineffective atrial contraction. Electrocardiographic characteristics of AF include: irregularly irregular R-R intervals (when atrioventricular conduction is not impaired), absence of distinct repeating P waves, and irregular atrial activations. Different AF classifications have been proposed but, traditionally, four patterns of AF are distinguished, based on presentation, duration, and spontaneous termination of AF episodes. Paroxysmal AF, that terminates spontaneously or with intervention within 7 days of onset. Persistent AF that is continuously sustained beyond 7 days, including episodes terminated by cardioversion (drugs or electrical cardioversion) after \>7 days. Long-standing persistent (continuous AF of \>12 months' duration) when decided to adopt a rhythm control strategy. Permanent AF, that is accepted by the patient and physician, and no further attempts to restore/maintain sinus rhythm will be undertaken. The purpose of this study is to perform assessments of local impedance before and after cryoablation performed with the new POLAR X cryoballoon, in order to characterize the quality of the lesion and possibly to associate it with the acute success and 12 months AF recurrence-free rate.

Conditions

Timeline

Start date
2021-09-15
Primary completion
2023-03-15
Completion
2023-03-15
First posted
2022-06-08
Last updated
2023-09-07

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05410379. Inclusion in this directory is not an endorsement.